Lantern Pharma Inc. - LTRN

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$4.066M

QoQ value delta ($000)

-$2.91M (-41.71%)

Implied price effect (QoQ)

-46.14%

Total shares

2,496,720

QoQ shares delta

+189,414 (+8.21%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 33 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BIOS Capital Management, LP	1,184	864,435	2.24%
VANGUARD GROUP INC	1,163	384,041	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	454	332,079	0.0%
CM Management, LLC	342	250,000	0.29%
RENAISSANCE TECHNOLOGIES LLC	158	116,000	0.0%
GEODE CAPITAL MANAGEMENT, LLC	152	111,646	0.0%
Westside Investment Management, Inc.	68	50,050	0.01%
Voss Capital, LP	68	50,000	0.0%
VANGUARD FIDUCIARY TRUST CO	67	49,607	0.0%
BlackRock, Inc.	62	45,267	0.0%
DIMENSIONAL FUND ADVISORS LP	52	38,060	0.0%
CIBC Private Wealth Group LLC	46	15,432	0.0%
NewEdge Advisors, LLC	37	27,399	0.0%
HORIZON KINETICS ASSET MANAGEMENT LLC	36	26,373	0.0%
STATE STREET CORP	32	23,652	0.0%
DAVENPORT & Co LLC	32	23,814	0.0%
Bank of New York Mellon Corp	29	21,301	0.0%
NORTHERN TRUST CORP	21	15,589	0.0%
Focus Partners Wealth	21	15,432	0.0%
Cetera Investment Advisers	16	12,228	0.0%
UBS Group AG	13	10,077	0.0%
Tower Research Capital LLC (TRC)	4	3,569	0.0%
Vanguard Global Advisers, LLC	3	2,355	0.0%
WELLS FARGO & COMPANY/MN	2	1,475	0.0%
SBI Securities Co., Ltd.	2	2,144	0.0%